Last updated on March 2020

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Brief description of study

The main purpose of this study is to investigate the safety, tolerability, and efficacy of the study drug known as LY3454738 in healthy participants and participants with atopic dermatitis. The study has three parts. Each participant will enroll in one part. The study will last 12 to 24 weeks, depending on part.

Clinical Study Identifier: NCT03750643

Find a site near you

Start Over

Premier Clinical Research

Spokane, WA United States
  Connect »